What's breaking now, across thousands of outlets.
"A very exciting addition to the field." Don't miss a story, subscribe here.
We haven't written up this one. ScienceAlert has the full story — the link below goes straight to it.
Defence Secretary Wes Streeting's national campaign on preparedness for cyber or climate emergencies dominates today's papers.
The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach to treating the cancer.
New research on GLP-1 drug usage from EY-Parthenon shows that weight loss is now the most popular use of the drug once dedicated to diabetes patients.
Consumer sentiment in the U.K. tumbled at the fastest pace since the Covid-19 pandemic this month as mounting cost-of-living pressures reversed the bounce in optimism seen over the summer.
Switzy is an impressive, surprising novel that tackles a big topic: assisted dying, and how we might meet our own cognitive decline.
The US plans to require air travelers to attest they haven't visited the Ebola-hit DRC in 21 days, tightening screening measures from November 3.
